A REVIEW OF CONCERTA KTOMALEK

Treatment was initiated at 36 mg/day and patients continued with incremental will increase of eighteen mg/working day (36 to 108 mg/working day) determined by Assembly unique improvement criteria with satisfactory tolerability. At the final analyze stop by, necessarily mean improve scores (LS Imply, SEM) to the investigator score over the AISRS dem